Imunon, Inc. (IMNN)
$1.08+0.93%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- 2.01
- P/E (TTM)
- -0.25
- Short % float
- 6.96%
- Days to cover
- 1.2
- SI change
- -10.6%
- 1W
- -15.62%
- 1M
- -25.52%
- vs SPY 1W
- -16.79%
- vs SPY 1M
- -28.51%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IMNN?
- LOPJLB’s latest quantitative signal on Imunon, Inc. (IMNN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IMNN in?
- Imunon, Inc. (IMNN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Imunon, Inc. (IMNN) do?
- Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline features GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a proprietary heat-activated liposomal formulation of doxorubicin, curren…